Key result
Anti-Angptl4-neutralizing antibody reversed the effects of chronic intermittent hypoxia on LPL in adipose tissue and lungs, but did not reverse the inhibition of triglyceride uptake.
Why the study?
Does an anti-Angptl4-neutralizing antibody reverse the inhibitory effects of chronic intermittent hypoxia on triglyceride uptake in male C57BL/6J mice?
Does an anti-Angptl4-neutralizing antibody reverse the inhibitory effects of chronic intermittent hypoxia on triglyceride uptake in male C57BL/6J mice?
Chronic intermittent hypoxia inactivates LPL by upregulating Angptl4, but its inhibition of triglyceride uptake occurs predominantly via an Angptl4/LPL-independent mechanism.
Anti-Angptl4 neutralization fails to restore triglyceride uptake despite LPL reversal in hypoxia models; leaves open predominant Angptl4-independent pathways.
Chronic intermittent hypoxia (CIH) inhibits plasma lipoprotein clearance and adipose lipoprotein lipase (LPL) activity in association with upregulation of an LPL inhibitor angiopoietin-like protein 4 (Angptl4). We hypothesize that CIH inhibits triglyceride (TG) uptake via Angptl4 and that an anti-Angptl4-neutralizing antibody would abolish the effects of CIH. Male C57BL/6J mice were exposed to four weeks of CIH or intermittent air (IA) while treated with Ab (30 mg/kg ip once a week). TG clearance was assessed by [H(3)]triolein administration retroorbitally. CIH delayed TG clearance and suppressed TG uptake and LPL activity in all white adipose tissue depots, brown adipose tissue, and lungs, whereas heart, liver, and spleen were not affected. CD146+ CD11b- pulmonary microvascular endothelial cells were responsible for TG uptake in the lungs and its inhibition by CIH. Antibody to Angptl4 decreased plasma TG levels and increased TG clearance and uptake into adipose tissue and lungs in both control and CIH mice to a similar extent, but did not reverse the effects of CIH. The antibody reversed the effects of CIH on LPL in adipose tissue and lungs. In conclusion, CIH inactivates LPL by upregulating Angptl4, but inhibition of TG uptake occurs predominantly via an Angptl4/LPL-independent mechanism.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2013) studied Chronic intermittent hypoxia. Anti-Angptl4-neutralizing antibody vs. Intermittent air (IA) was evaluated on Triglyceride (TG) clearance and uptake. Anti-Angptl4-neutralizing antibody reversed the effects of chronic intermittent hypoxia on LPL in adipose tissue and lungs, but did not reverse the inhibition of triglyceride uptake.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: